Breaking New Ground in Cancer, Immune Disorders and Infection
This daylong in person and virtual event will highlight the state-of-the-art research taking place at RFUMS and detail the novel approaches being developed for diagnosing and treating a wide range of diseases.
Wednesday, October 18, 2023
8:45 a.m. - 5:00 p.m. CDT
John Leonard, MD
“Changing Life Stories with Genome Editing Therapies”
President and Chief Executive Officer, Intellia Therapeutics, Head, Global Pharmaceutical R&D, Abbott and AbbVie, Retired
Other speakers include: